Bodrexin may be available in the countries listed below.
Ingredient matches for Bodrexin
Acetylsalicylic Acid is reported as an ingredient of Bodrexin in the following countries:
- Indonesia
International Drug Name Search
Bodrexin may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Bodrexin in the following countries:
International Drug Name Search
Onium may be available in the countries listed below.
Tiemonium Methylsulfate is reported as an ingredient of Onium in the following countries:
International Drug Name Search
Harmomed may be available in the countries listed below.
Diazepam is reported as an ingredient of Harmomed in the following countries:
Dosulepin hydrochloride (a derivative of Dosulepin) is reported as an ingredient of Harmomed in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Yohimbine hydrochloride (a derivative of Yohimbine) is reported as an ingredient of Antagonil in the following countries:
International Drug Name Search
Fordiab may be available in the countries listed below.
Gliquidone is reported as an ingredient of Fordiab in the following countries:
International Drug Name Search
Ancobon is a brand name of flucytosine, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Ancobon:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ancobon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Ancobon.
Citaxin may be available in the countries listed below.
Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citaxin in the following countries:
International Drug Name Search
Treating vitamin A deficiency. It may also be used for other conditions as determined by your doctor.
Beta-Carotene is a precursor to vitamin A, a fat-soluble vitamin.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Beta-Carotene. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Beta-Carotene. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Beta-Carotene may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Beta-Carotene as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Beta-Carotene.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Beta-Carotene side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Beta-Carotene at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Beta-Carotene out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Beta-Carotene. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Strumazol may be available in the countries listed below.
Thiamazole is reported as an ingredient of Strumazol in the following countries:
International Drug Name Search
Treating infections caused by certain bacteria.
Duricef is a cephalosporin antibiotic. It works by interfering with the bacteria's cell wall formation. This weakens the cell wall, causing it to rupture, resulting in death of the bacteria.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Duricef. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Duricef. However, no specific interactions with Duricef are known at this time.
Ask your health care provider if Duricef may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Duricef as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Duricef.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea; nausea; stomach upset; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody diarrhea; dark urine; decreased urination; fever, chills, or sore throat; joint pain; red, swollen, or blistered skin; seizures; severe diarrhea; stomach pain or cramps; unusual bruising or bleeding; unusual tiredness or weakness; vaginal itching, odor, or discharge; yellowing of the skin or eyes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Duricef side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include muscle spasms; seizures.
Store Duricef at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Duricef out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Duricef. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Lamotrigina Arrowblue may be available in the countries listed below.
Lamotrigine is reported as an ingredient of Lamotrigina Arrowblue in the following countries:
International Drug Name Search
Tranquirit may be available in the countries listed below.
Diazepam is reported as an ingredient of Tranquirit in the following countries:
International Drug Name Search
Braunoderm may be available in the countries listed below.
Isopropyl Alcohol is reported as an ingredient of Braunoderm in the following countries:
Povidone-Iodine is reported as an ingredient of Braunoderm in the following countries:
International Drug Name Search
D Vital may be available in the countries listed below.
Calcium Carbonate is reported as an ingredient of D Vital in the following countries:
Colecalciferol is reported as an ingredient of D Vital in the following countries:
International Drug Name Search
Apo-Desipramine may be available in the countries listed below.
Desipramine hydrochloride (a derivative of Desipramine) is reported as an ingredient of Apo-Desipramine in the following countries:
International Drug Name Search
Sertralina Pharmagenus may be available in the countries listed below.
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Pharmagenus in the following countries:
International Drug Name Search
Cotrisan may be available in the countries listed below.
Clotrimazole is reported as an ingredient of Cotrisan in the following countries:
International Drug Name Search
Almagel may be available in the countries listed below.
Aluminium Hydroxide hydrate (Algeldrate) (a derivative of Aluminium Hydroxide) is reported as an ingredient of Almagel in the following countries:
Magnesium Hydroxide is reported as an ingredient of Almagel in the following countries:
International Drug Name Search
Peledox may be available in the countries listed below.
Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Peledox in the following countries:
International Drug Name Search
Clinax may be available in the countries listed below.
Minocycline is reported as an ingredient of Clinax in the following countries:
Sulindac is reported as an ingredient of Clinax in the following countries:
International Drug Name Search
Buten may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Buten in the following countries:
International Drug Name Search
Loratadina Rimafar may be available in the countries listed below.
Loratadine is reported as an ingredient of Loratadina Rimafar in the following countries:
International Drug Name Search
Oximinth may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Dichlorvos is reported as an ingredient of Oximinth in the following countries:
Oxibendazole is reported as an ingredient of Oximinth in the following countries:
International Drug Name Search
Conducil may be available in the countries listed below.
Nifedipine is reported as an ingredient of Conducil in the following countries:
International Drug Name Search
Generic Name: carmustine (Intravenous route)
kar-MUS-teen
Bone marrow suppression, notably thrombocytopenia and leukopenia, which may contribute to bleeding and overwhelming infections in an already compromised patient, is the most common and severe of the toxic effects of carmustine. Blood counts should be monitored weekly for at least 6 weeks after a dose. At the recommended dosage, courses of carmustine should not be given more frequently than every 6 weeks. Pulmonary toxicity from carmustine appears to be dose related, as patients receiving greater than 1400 mg/m(2) cumulative dose are at significantly higher risk than those receiving less. Delayed pulmonary toxicity can occur years after treatment, and can result in death, particularly in patients treated in childhood .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antineoplastic Agent
Pharmacologic Class: Alkylating Agent
Chemical Class: Nitrosourea
Carmustine injection is used alone or together with other medicines to treat certain type of brain tumors (e.g., glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors), cancer of the lymph system (e.g., Hodgkin's disease, non-Hodgkin's lymphoma), and a certain type of cancer in the bone marrow (e.g., multiple myeloma). It may also be used to treat other kinds of cancer, as determined by your doctor.
Carmustine belongs to the group of alkylating agents. It interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by carmustine, other effects may occur. Some of these may be serious and must be reported to your doctor. Other effects (e.g., hair loss), may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.
Before you begin treatment with carmustine, you and your doctor should talk about the benefits this medicine will do as well as the risks.
This medicine is to be administered only by or under the immediate supervision of your doctor.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, carmustine injection is used in certain patients with the following conditions:
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies on the relationship of age to the effects of carmustine injection have not been performed in the pediatric population. Safety and efficacy have not been established.
No information is available on the relationship of age to the effects of carmustine injection in geriatric patients. However, elderly patients are more likely to have age-related kidney, liver, or heart problems, which may require caution and an adjustment in the dose for patients receiving carmustine injection.
Pregnancy Category | Explanation | |
---|---|---|
All Trimesters | D | Studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment.
A nurse or other trained health professional will give you this medicine in a hospital. This medicine is given through a needle placed in one of your veins.
This medicine is usually given every 6 weeks. This maybe given as a single dose or divided into daily injections on two consecutive days.
Carmustine is sometimes given together with certain other medicines. If you are using a combination of medicines, it is important that you receive each one at the proper time. If you are taking some of these medicines by mouth, ask your doctor to help you plan a way to take them at the right times.
This medicine often causes nausea and vomiting, which usually last no longer than 4 to 6 hours. It is very important that you continue to receive the medicine, even if you begin to feel ill. Ask your doctor for ways to lessen these effects.
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood and urine tests may be needed to check for unwanted effects.
Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. If you think you have become pregnant while using the medicine, tell your doctor right away.
This medicine may increase your risk of developing cancer and lung problems (such as pulmonary fibrosis or toxicity). This is more likely if you receive high doses of this medicine or use it for a long time.
While you are being treated with carmustine injection, and after you stop treatment with it, do not have any immunizations (vaccines) without your doctor's approval. Carmustine may lower your body's resistance and the vaccine may not work as well for you or you might get the infection the vaccine is meant to prevent. In addition, you should not be around other persons living in your household who receive live vaccines because there is a chance they could pass the virus on to you. Some examples of live vaccines include measles, mumps, influenza (nasal flu vaccine), poliovirus (oral form), rotavirus, and rubella. Do not get close to them and do not stay in the same room with them for very long. If you have questions about this, talk to your doctor.
Carmustine can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
If carmustine accidentally seeps out of the vein into which it is injected, it may damage some tissues and cause scarring. Tell the doctor or nurse right away if you notice redness, pain, or swelling at the injection site.
This medicine may increase risk of lung problems while smoking.
Along with its needed effects, medicines like carmustine can sometimes cause some unwanted effects such as blood problems, loss of hair, and other side effects ; these are described below. Also, because of the way these medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer, such as leukemia. Discuss these possible effects with your doctor.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Bicnu side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Ranitidina Combix may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidina Combix in the following countries:
International Drug Name Search
Diclofenacnatrium FLX may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenacnatrium FLX in the following countries:
International Drug Name Search
Phorpain may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Phorpain in the following countries:
International Drug Name Search
Rec.INN
G03CA09
0039219-28-8
C22-H32-O2
328
Estrogen
Estra-1,3,5(10)-triene, 17-methoxy-3-propoxy-, (17ß)-
International Drug Name Search
Glossary
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Vironida LCH may be available in the countries listed below.
Aciclovir is reported as an ingredient of Vironida LCH in the following countries:
International Drug Name Search
Azlaire may be available in the countries listed below.
Pranlukast is reported as an ingredient of Azlaire in the following countries:
Pranlukast hemihydrate (a derivative of Pranlukast) is reported as an ingredient of Azlaire in the following countries:
International Drug Name Search
Traumus may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Traumus in the following countries:
International Drug Name Search
Spasmin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Spasmin in the following countries:
Scopolamine is reported as an ingredient of Spasmin in the following countries:
International Drug Name Search
Generic Name: fluocinolone (Topical application route)
floo-oh-SIN-oh-lone a-SEET-oh-nide
In the U.S.
In Canada
Available Dosage Forms:
Therapeutic Class: Corticosteroid, Intermediate
Pharmacologic Class: Fluocinolone
Fluocinolone topical is used to relieve redness, itching, swelling, or other discomfort caused by skin conditions. Fluocinolone scalp oil is used to treat psoriasis of the scalp, and fluocinolone shampoo for seborrheic dermatitis of the scalp. This medicine is a corticosteroid (cortisone-like medicine or steroid).
This medicine is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of fluocinolone topical in the pediatric population. However, because of this medicine's toxicity, it should be used with caution. Children may absorb large amounts through the skin, which can cause serious side effects. If your child is using this medicine, follow your doctor's instructions very carefully. For the body oil form, safety and efficacy in children 3 months of age and younger have not been established.
No information is available on the relationship of age to the effects of fluocinolone topical in geriatric patients.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain fluocinolone. It may not be specific to Derma-Smoothe/FS. Please read with care.
It is very important that you use this medicine only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may cause unwanted side effects or skin irritation.
This medicine is for use on the skin only. Do not get it in your eyes. Do not use it on skin areas that have cuts, scrapes, or burns. If it does get on these areas, rinse it off right away with water.
This medicine should only be used for skin conditions that your doctor is treating. Check with your doctor before using it for other conditions, especially if you think that a skin infection may be present. This medicine should not be used to treat certain kinds of skin infections or conditions, such as severe burns.
To use cream, ointment, solution, and body oil:
To use shampoo:
To use scalp oil:
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check the progress of you or your child at regular visits for any unwanted effects that may be caused by this medicine.
If your or your child's symptoms do not improve within a few days, or if they become worse, check with your doctor.
Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. The risk is greater for children and patients who use large amounts for a long time. Talk to your doctor right away if you or your child have more than one of these symptoms while you are using this medicine: blurred vision; dizziness or fainting; a fast, irregular, or pounding heartbeat; increased thirst or urination; irritability; or unusual tiredness or weakness.
Stop using this medicine and check with your doctor right away if you or your child have a skin rash, burning, stinging, swelling, or irritation on the skin.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Derma-Smoothe/FS side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Sucralan may be available in the countries listed below.
Sucralfate is reported as an ingredient of Sucralan in the following countries:
International Drug Name Search
Levoxal may be available in the countries listed below.
Levofloxacin is reported as an ingredient of Levoxal in the following countries:
Levofloxacin hemihydrate (a derivative of Levofloxacin) is reported as an ingredient of Levoxal in the following countries:
International Drug Name Search
Sebolox may be available in the countries listed below.
Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Sebolox in the following countries:
International Drug Name Search
Rec.INN
N05CM03
0000496-67-3
C6-H11-Br-N2-O2
223
Hypnotic and sedative agent
Butanamide, N-(aminocarbonyl)-2-bromo-3-methyl-
International Drug Name Search
Glossary
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Ufarin may be available in the countries listed below.
Isoconazole nitrate (a derivative of Isoconazole) is reported as an ingredient of Ufarin in the following countries:
International Drug Name Search
Noginox may be available in the countries listed below.
Isoconazole nitrate (a derivative of Isoconazole) is reported as an ingredient of Noginox in the following countries:
International Drug Name Search
Weiliufen may be available in the countries listed below.
Sulfasalazine is reported as an ingredient of Weiliufen in the following countries:
International Drug Name Search
Proleak may be available in the countries listed below.
Finasteride is reported as an ingredient of Proleak in the following countries:
International Drug Name Search
Rheumafen may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Rheumafen in the following countries:
International Drug Name Search
Budesonida Aldo Union Nasal may be available in the countries listed below.
Budesonide is reported as an ingredient of Budesonida Aldo Union Nasal in the following countries:
International Drug Name Search
Zolen may be available in the countries listed below.
Amisulpride is reported as an ingredient of Zolen in the following countries:
Fluconazole is reported as an ingredient of Zolen in the following countries:
International Drug Name Search
Diflu may be available in the countries listed below.
Fluconazole is reported as an ingredient of Diflu in the following countries:
International Drug Name Search
Metronidazol Arcana may be available in the countries listed below.
Metronidazole is reported as an ingredient of Metronidazol Arcana in the following countries:
International Drug Name Search
Bleomycin Hydrochloride may be available in the countries listed below.
Bleomycin Hydrochloride (JAN) is known as Bleomycin in the US.
International Drug Name Search
Glossary
JAN | Japanese Accepted Name |
Citiflux may be available in the countries listed below.
Flunisolide is reported as an ingredient of Citiflux in the following countries:
International Drug Name Search
Saphire may be available in the countries listed below.
Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Saphire in the following countries:
International Drug Name Search
Meliane may be available in the countries listed below.
Ethinylestradiol is reported as an ingredient of Meliane in the following countries:
Gestodene is reported as an ingredient of Meliane in the following countries:
International Drug Name Search
Sucedal may be available in the countries listed below.
Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Sucedal in the following countries:
International Drug Name Search
Micar may be available in the countries listed below.
Piroxicam is reported as an ingredient of Micar in the following countries:
International Drug Name Search
Zynovate may be available in the countries listed below.
Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Zynovate in the following countries:
International Drug Name Search
Zurocid may be available in the countries listed below.
Simvastatin is reported as an ingredient of Zurocid in the following countries:
International Drug Name Search
Fefun may be available in the countries listed below.
Nystatin is reported as an ingredient of Fefun in the following countries:
International Drug Name Search
Nicholin H may be available in the countries listed below.
Citicoline is reported as an ingredient of Nicholin H in the following countries:
International Drug Name Search
In the US, Dysport (abobotulinumtoxinA systemic) is a member of the drug class skeletal muscle relaxants and is used to treat Cervical Dystonia and Facial Wrinkles.
US matches:
UK matches:
Botulinum A Toxin is reported as an ingredient of Dysport in the following countries:
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Lisinopril Atid may be available in the countries listed below.
Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril Atid in the following countries:
International Drug Name Search
Gacida may be available in the countries listed below.
Aluminium Hydroxide is reported as an ingredient of Gacida in the following countries:
Magnesium Trisilicate is reported as an ingredient of Gacida in the following countries:
International Drug Name Search
Levomycetinum may be available in the countries listed below.
Chloramphenicol is reported as an ingredient of Levomycetinum in the following countries:
International Drug Name Search
Simvastatina Grapa may be available in the countries listed below.
Simvastatin is reported as an ingredient of Simvastatina Grapa in the following countries:
International Drug Name Search
Ticlopidina Genfar may be available in the countries listed below.
Ticlopidine is reported as an ingredient of Ticlopidina Genfar in the following countries:
International Drug Name Search